In a 52-week clinical trial with 62 patients aged 6 years and older with AFRS, some patients saw improvements in nasal congestion in as early as one month.* Patients experienced an 81% reduction at week 52, compared to 11% on placebo.

*Analysis at one month was not evaluated during the clinical trial, and any results at one month may be due to chance. Individual results may vary.